Related Experiment Video
Updated: Aug 10, 2026

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
Evaluation of flurazepam and placebo on sleep disorders in childhood
Insights
Flurazepam significantly improved sleepwalking, sleep-talking, bruxism, sleep terror, and excessive movements in children. Some patients experienced side effects like daytime drowsiness.
Area of Science:
- Pediatric Sleep Medicine
- Clinical Pharmacology
Background:
- Sleep disturbances are common in children.
- Investigating effective treatments for pediatric sleep disorders is crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of flurazepam in treating sleep disturbances in children.
- To compare flurazepam's effects against a placebo.
Main Methods:
- A randomized, placebo-controlled study involving 40 pediatric patients (1-15 years old).
- Patients received flurazepam (15mg daily) or placebo for 14 days each, in a crossover design.
- Evaluated chief complaints including sleepwalking, sleep-talking, sleep terror, bruxism, headbanging, insomnia, and excessive movements.
Main Results:
- Flurazepam demonstrated significant efficacy in reducing sleepwalking, sleep-talking, bruxism, sleep terror, and excessive movements.
- Side effects of flurazepam included daytime drowsiness, irritability, and nausea/vomiting.
- Two cases required discontinuation due to persistent excessive daytime drowsiness.
Conclusions:
- Flurazepam is an effective treatment for several pediatric sleep disturbances.
- Careful monitoring for side effects, particularly daytime drowsiness, is recommended.
- Further research is needed for sleep-related headbanging in pediatric populations.
Abstract:
The clinically observed results in 40 patients, from 1 to 15 years old, presenting sleep disturbances, in a comparative and statistically approached study of flurazepam 15mg daily against placebo, are reported. Placebo was administered, followed by the drug, during 14 days each. The chief complaints were sleepwalking, sleep-talking, sleep terror, sleep-related bruxism, sleep-related headbanging, insomnia and excessive movements during sleep. A significant effect of flurazepam on sleepwalking, sleep-talking, bruxism, sleep terror and excessive movement during sleep, was observed. The insomniac headbanging patients were not enough for statistical analysis. Flurazepam side effects were excessive drowsiness during daytime in 3 cases; irritability, 3 cases; nausea and vomiting, 2 cases, and were not correlated with age. Placebo side effects were similar, except for nausea and vomiting which were not observed. It was necessary to discontinue flurazepam in 2 cases, because of excessive drowsiness during daytime, which did not improve when reducing the dose.
More Related Videos
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Related Concept Videos
Blind Procedures
Management of Insomnia
REM Sleep Behavior Disorder
RBD is significantly associated with...